Trials / Conditions / Purpura, Thrombotic Thrombocytopenic
Purpura, Thrombotic Thrombocytopenic
5 registered clinical trials studyying Purpura, Thrombotic Thrombocytopenic.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | IdeS in Asymptomatic Antibody-Mediated Thrombotic Thrombocytopenic Purpura (TTP) Patients NCT02854059 | Hansa Biopharma AB | Phase 2 |
| Completed | A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura NCT01808521 | Bloodworks | EARLY_Phase 1 |
| Withdrawn | Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura NCT01754545 | St. Olavs Hospital | Phase 4 |
| Withdrawn | The Plasma Large-Volume Exchange RCT NCT01433003 | London Health Sciences Centre | Phase 3 |
| Completed | ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders NCT00632242 | Archemix Corp. | Phase 2 |